Open-Label, Safety Study of Lofexidine

NCT02363998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Withdrawal

Interventions

DRUG: Lofexidine

Sponsor

USWM, LLC (dba US WorldMeds)

Collaborators

[object Object]